Medication classification | HbA1c classification | n | Baseline mean ± SD | After administration mean ± SD | Difference | |
---|---|---|---|---|---|---|
All patients | Total | 2086 | 8.46 ± 1.40 | 7.71 ± 1.31 | -0.76 ± 1.38 § |  |
 | 7-8% | 1010 | 7.46 ± 0.29 | 7.20 ± 0.77 | -0.25 ± 0.74 § | p < 0.001 |
 | 8-9% | 555 | 8.44 ± 0.28 | 7.75 ± 1.02 | -0.69 ± 1.01 § |  |
 | ≥9% | 521 | 10.45 ± 1.29 | 8.64 ± 1.79 | -1.81 ± 1.97 § |  |
Diabetes drug use | Subtotal | 254 | 7.84 ± 1.04 | 7.28 ± 1.00 | -0.56 ± 1.06 § |  |
Before study: not taken & | 7-8% | 186 | 7.38 ± 0.26 | 7.06 ± 0.67 | -0.32 ± 0.66 | p < 0.001 |
During study: not taken | 8-9% | 46 | 8.38 ± 0.26 | 7.64 ± 1.08 | -0.74 ± 1,03 § |  |
 | ≥9% | 22 | 10.64 ± 1.24 | 8.48 ± 1.85 | -2.16 ± 2.03 § |  |
 | Subtotal | 397 | 8.89 ± 1.66 | 7.42 ± 1.36 | -1.47 ± 1.88 § |  |
Before study: not taken & | 7-8% | 147 | 7.46 ± 0.29 | 7.06 ± 0.85 | -0.39 ± 0.86 § | p < 0.001 |
During study: taken | 8-9% | 109 | 8.45 ± 0.29 | 7.31 ± 0.96 | -1.15 ± 0.97 § |  |
 | ≥9% | 141 | 10.73 ± 1.40 | 7.89 ± 1.84 | -2.84 ± 2.30 § |  |
 | Subtotal | 59 | 8.26 ± 1.33 | 7.79 ± 1.23 | -0.47 ± 1.10 ‡ |  |
Before study: taken & | 7-8% | 34 | 7.48 ± 0.28 | 7.26 ± 0.83 | -0.22 ± 0.85 | p = 0.003 |
During study: not taken | 8-9% | 14 | 8.50 ± 0.28 | 8.09 ± 1.03 | -0.41 ± 0.93 |  |
 | ≥9% | 11 | 10.38 ± 1.67 | 9.05 ± 1.51 | -1.32 ± 1.59 †|  |
 | Subtotal | 1376 | 8.46 ± 1.33 | 7.86 ± 1.31 | -0.60 ± 1.20 § |  |
Before study: taken & | 7-8% | 643 | 7.48 ± 0.29 | 7.28 ± 0.76 | -0.20 ± 0.73 § | p < 0.001 |
During study: taken | 8-9% | 386 | 8.44 ± 0.27 | 7.88 ± 1.00 | -0.56 ± 0.98 § |  |
 | ≥9% | 347 | 10.32 ± 1.22 | 8.94 ± 1.69 | -1.38 ± 1.66 § |  |